APT070 Inhibits Complement Activation During in Vitro Cardiopulmonary Bypass
We looked at the effect of APT070, an anti-complement agent, on human blood during in vitro CPB.
You may also like
Does Mitral Valve Repair Offer an Advantage Over Replacement in Patients Undergoing Aortic Valve Replacement
We utilized the Society of Thoracic Surgeons Adult Cardiac Surgery Database (ACSD) to evaluate outcomes for patients undergoing combined aortic valve replacement (AVR) and MV repair or replacement.
1 min read
Intraoperative Transfusion of 1 U to 2 U Packed Red Blood Cells Is Associated with Increased 30-Day Mortality, Surgical-Site Infection, Pneumonia, and Sepsis in General Surgery Patients
Among surgical patients receiving transfusions of packed RBCs (PRBCs), the incidence and degree of transfusion-related immunomodulation are related to, among other factors, the type of product transfused and patient parameters.
2 min read